Action PRGO PERRIGO COMPANY PLC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Perrigo Company plc TEL AVIV STOCK EXCHANGE

Actions

PRGO

IE00BGH1M568

Temps Différé TEL AVIV STOCK EXCHANGE
Autres places de cotation
 		Varia. 5j. Varia. 1 janv.
- ILa -.--% Graphique intraday de Perrigo Company plc -2,55 % -3,73 %
10/07 Esteve Healthcare S.L. a finalisé l'acquisition de HRA Pharma Rare Diseases America, LLC auprès de Perrigo Company plc. CI
13/06 PERRIGO COMPANY PLC : Piper Sandler à l'achat ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
Esteve Healthcare S.L. completed the acquisition of HRA Pharma Rare Diseases America, LLC from Perrigo Company plc.
Perrigo Company plc Appoints Todd Penegor as Member of Board and to Serve on Audit Committee, Effective June 21, 2024
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
Perrigo Company plc Announces Executive Changes
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
Perrigo's Q1 Adjusted Earnings, Net Sales Drop
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23
Perrigo: Q1 Earnings Snapshot
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024
Perrigo Company plc Reaffirms Earnings Guidance Year 2024 and Provides Sales Guidance for the Second Half of 2024
Perrigo Announces Executive Transition for Its Consumer Self-Care International Business
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31
Perrigo Announces Quarterly Dividend
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024
Sector Update: Health Care Stocks Decline Late Afternoon
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PRGO
  4. Action PRGO
  5. Actualités Perrigo Company plc
  6. Autres langues